1Goldhaber SZ,Haire WD,Feldstein ML,et al.Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion[].The Lancet.1993
2Konstantinides S,Geibel A,Olschewski M,et al.Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry[].Circulation.1997
3Girard P,Musset D,Parent F,et al.High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism[].Chest.1999
4Decousus H,Leizorovicz A,Parent F,et al.A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis.Prevention du Risque d′Embolie Pulmonaire par Interruption Cave Study Group[].The New England Journal of Medicine.1998
5Simonneau G,Sors H,Charbonnier B,et al.A comparison of lowmolecular-weight heparin with unfractionated heparin for acute pulmonary embolism.The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l′Embolie Pulmonaire[].The New England Journal of Medicine.1997
6Tebbe U,Graf A,Kamke W,et al.Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism[].American Heart Journal.1999
7Ribeiro A,Lindmarker P,Juhlin-Dannfelt A,et al.Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate[].American Heart Journal.1997
8Carson JL,Kelley MA,Duff A,et al.The clinical course of pulmonary embolism[].The New England Journal of Medicine.1992
